Skip to main content
. 2017 Apr 2;6(3):210–219. doi: 10.15171/jnp.2017.35

Table 3. Sensitivity, intermediate resistance, and resistance frequency of some isolated gram negative bacteria to different tested antimicrobials during 2013, 2014, and 2015 at the nephrology ward .

Antimicrobial agent/Microorganism Sensitive (n) Intermediate (n) Resistant (n)
2013 2014 2015 2013 2014 2015 2013 2014 2015
Escherichia coli
Trimethoprim/Sulfamethoxazole 8 14 6 - - - 5 42 17
Ciprofloxacin 17 18 7 1 1 1 41 38 16
Chloramphenicol 8 10 5 3 - - 1 1 1
Nitrofurantoin - 35 15 - 10 2 12 6 -
Amikacin - 27 12 24 18 7 11 13 4
Gentamicin - 39 12 - 3 - - 20 10
Imipenem - 1 3 1 - - 2 2 3
Colistin - - 6 - - - - - -
Cefixime 12 15 5 1 1 - - 39 18
Ceftriaxone - 13 5 1 - - 36 34 14
Ceftizoxime - 13 - - 4 - 37 24 4
Ceftazidime - - - - - - - 1 -
Cefotaxime - 5 5 - - - 1 13 12
Cephalexin - 10 4 - 1 2 43 40 17
Total 45 200 101 31 38 12 189 273 116
Percent 16.9 39.1 44.1 11.7 7.4 5.2 71.3 53.4 50.7
Klebsiella spp.
Trimethoprim/Sulfamethoxazole 7 12 2 - - - 12 11 5
Ciprofloxacin 11 15 4 - - 2 8 8 3
Chloramphenicol 9 6 3 - - - 2 3 -
Nitrofurantoin 2 1 - 2 2 1 7 11 3
Amikacin 8 12 3 - 4 5 8 6 1
Gentamicin 15 16 2 - - 1 5 8 4
Imipenem 4 - 2 - - 1 - 1 2
Colistin - - 3 - - - - - -
Cephalexin - 8 1 - - - - 15 6
Cefixime - 9 2 - - - - 12 5
Ceftizoxime - 9 1 - 1 2 - - 3
Ceftriaxone - 5 1 - 1 - - 7 3
Cefotaxime - 2 1 - - - - 10 2
Ceftazidime - - - - - - - 1 -
Total 56 96 25 2 8 12 42 93 37
Percent 56 48.7 33.8 2 4.1 16.2 42 47.2 50
Acinetobacter spp.
Trimethoprim/Sulfamethoxazole - - - - - 1 19 10 6
Ciprofloxacin 4 - - - - 1 15 14 7
Nitrofurantoin - - - - - - 7 5 -
Chloramphenicol - - - - - - 13 8 5
Amikacin - 1 - - - - 13 11 7
Gentamicin 1 1 - 1 - - 16 12 7
Imipenem 1 - - - - - 3 3 7
Colistin - 2 7 - - - - - -
Ceftazidime - - - - - - - 2 3
Cefixime - - - - - - - 14 7
Ceftizoxime - 1 - - - - - 6 4
Cefotaxime - - - - - - - 6 1
Ceftriaxone - 1 - - - - - 5 2
Total 6 6 7 1 - 2 86 96 56
Percent 6.5 5.9 10.8 1.1 - 3.1 92.5 94.1 86.2
Pseudomonas aeruginosa
Trimethoprim/Sulfamethoxazole - - - - - - 6 4 3
Ciprofloxacin 6 5 2 - - - 2 1 1
Nitrofurantoin - - - - - - 4 2 1
Chloramphenicol - - - - - - 4 2 1
Amikacin - 5 1 - - 1 5 1 -
Gentamicin - 4 1 - - - 4 1 2
Imipenem - - 2 - - - 1 - -
Colistin - - 2 - - 1 - - -
Ceftriaxone - 1 - 1 - - - 1 1
Cefixime - - - - - - - 4 3
Cefotaxime - - - - - - - 1 1
Ceftizoxime - 1 - - 1 - - 2 1
Total 6 16 8 1 1 2 26 19 14
Percent 18.2 44.4 33.3 3 2.8 8.3 78.8 52.8 58.3
Enterobacter spp.
Trimethoprim/Sulfamethoxazole 5 4 2 - 2 - 5 7 -
Ciprofloxacin 7 8 2 2 - - 4 4 -
Nitrofurantoin - 1 - - 1 - 3 - 1
Chloramphenicol 2 6 1 2 1 - 6 - -
Amikacin 6 4 2 1 2 - 4 2 -
Gentamicin 7 6 2 - - - 3 6 -
Imipenem - 2 1 - - - - - -
Colistin - 1 1 - - - - - -
Cefixime 3 6 2 2 - - 5 5 -
Ceftizoxime 6 4 1 - - - 3 - -
Ceftazidime - - - - 1 - 1 - -
Cefotaxime 1 - 1 - - - - 1 -
Ceftriaxone 3 2 1 - - - 1 1 -
Total 40 44 16 7 8 - 35 26 1
Percent 48.8 56.4 94.1 8.5 10.3 - 42.7 33.3 5.9